James Scibetta Insider Profile
4 Followers
James Scibetta, Director at Matinas BioPharma, holds 649.96K shares in Matinas BioPharma (Ticker: MTNB), holds 31.64K shares in Aquestive Therapeutics (Ticker: AQST), holds 27.08K shares in Pacira Pharmaceuticals (Ticker: PCRX).
James Scibetta's Trading History
You May Also Like
James Scibetta insider profile FAQ
What is the percentage of profitable transactions made by James Scibetta?
The percentage of profitable transactions made by James Scibetta is 67%.
What is the average return per transaction made by James Scibetta?
The average return per transaction made by James Scibetta is 17.50%.
What stocks does James Scibetta hold?
James Scibetta holds: MTNB, PCRX, AQST stocks.
What was James Scibetta's most profitable transaction?
James Scibetta’s most profitable transaction was an Informative Buy of AQST stock on August 22, 2019. The return on the trade was 103.20%.
What is James Scibetta's role in Matinas BioPharma?
James Scibetta's role in Matinas BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
